Kairos Pharma KAPA Growth Metrics (2023-2025)

NYSE KAPA
$0.30 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Growth Metrics Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 497.72%13.38%
Assets (QoQ) (Quarter) 15.27%37.60%-15.93%
Cash & Equivalents Growth (1y) (Quarter) 3,149.49%1,267.74%253.07%
Cash & Equivalents (QoQ) (Quarter) -6.06%-60.46%-99.72%86,486.76%
Cash from Operations Growth (1y) (Quarter) -2,831.82%-2,083.33%-379.17%
Cash from Operations (QoQ) (Quarter) -45.45%-566.67%-1,102.38%10.74%60.40%-12.75%
EBITDA Margin (QoQ) (Quarter) 36.00-38.00
EBIT Growth (1y) (Quarter) -33.45%-32.78%-341.11%-555.86%
EBIT Margin (QoQ) (Quarter) 36.00-38.00
EBIT (QoQ) (Quarter) -279.44%73.65%22.65%-72.52%-277.55%12.45%-15.01%
EBT Growth (1y) (Quarter) -204.64%-90.57%-411.55%-589.74%
EBT Margin (QoQ) (Quarter) 106.00-13.00
EBT (QoQ) (Quarter) -261.59%72.25%22.77%-293.16%-126.20%25.52%-4.13%
Enterprise Value Growth (1y) (Quarter) -3,149.49%-1,267.74%-253.07%
Enterprise Value (QoQ) (Quarter) 6.06%60.46%99.72%-86,486.76%
EPS (Basic) Growth (1y) (Quarter) -188.56%-74.22%-240.36%-323.26%
EPS (Basic) (QoQ) (Quarter) -259.91%72.73%22.77%-280.64%-117.31%46.72%3.96%
EPS (Diluted) Growth (1y) (Quarter) -188.56%-74.22%-240.36%-323.26%
EPS (Diluted) (QoQ) (Quarter) -259.91%72.73%22.77%-280.64%-117.31%46.72%3.96%
FCF Margin (QoQ) (Quarter) 218.00-18.00
Free Cash Flow Growth (1y) (Quarter) -2,831.82%-2,083.33%-379.17%
Free Cash Flow (QoQ) (Quarter) -45.45%-566.67%-1,102.38%10.74%60.40%-12.75%
Interest Coverage Ratio Growth (1y) (Quarter) 96.27%99.37%75.49%59.01%
Interest Coverage Ratio (QoQ) (Quarter) -1,797.21%95.06%-3.14%96.14%-219.28%-93.04%-72.51%
Net Cash Flow Growth (1y) (Quarter) -32,316.67%4,522.64%-2,963.16%
Net Cash Flow (QoQ) (Quarter) -783.33%64.15%16,921.05%-160.86%220.51%-124.83%
Net Income Growth (1y) (Quarter) -204.64%-90.57%-411.55%-589.74%
Net Income (QoQ) (Quarter) -261.59%72.25%22.77%-293.16%-126.20%25.52%-4.13%
Net Income towards Common Stockholders Growth (1y) (Quarter) -204.64%-90.57%-411.55%-589.74%
Net Income towards Common Stockholders (QoQ) (Quarter) -261.59%72.25%22.77%-293.16%-126.20%25.52%-4.13%
Net Margin (QoQ) (Quarter) 106.00-13.00
Operating Income Growth (1y) (Quarter) -33.45%-32.78%-341.11%-555.86%
Operating Income (QoQ) (Quarter) -279.44%73.65%22.65%-72.52%-277.55%12.45%-15.01%
Operating Margin (QoQ) (Quarter) 36.00-38.00
Profit After Tax Growth (1y) (Quarter) -235.58%12.34%-290.71%-462.06%
Profit After Tax (QoQ) (Quarter) -258.33%71.11%21.67%-313.83%6.40%-28.78%-12.68%
Return on Assets Growth (1y) (Quarter) 0.00
Return on Assets (QoQ) (Quarter) 0.000.00
Return on Capital Employed (QoQ) (Quarter) -164.00-1380.00
Return on Sales (QoQ) (Quarter) 0.000.00
Revenue (QoQ) (Quarter) 0.00%0.00%